Prestige Consumer Healthcare Inc. (PBH)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$1.11 (+1.31%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Prestige Consumer Healthcare Inc. (PBH)
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Key Insights

Critical company metrics and information

  • Share Price

    $85.82

  • Market Cap

    $4.24 Billion

  • Total Outstanding Shares

    49.41 Million Shares

  • Total Employees

    570

  • Dividend

    No dividend

  • IPO Date

    February 10, 2005

  • SIC Description

    Pharmaceutical Preparations

  • Homepage

    https://www.prestigebrands.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Financing Activities, Continuing$-250.01 Million
Net Cash Flow From Investing Activities, Continuing$-23.66 Million
Exchange Gains/Losses$2.18 Million
Net Cash Flow, Continuing$-10.71 Million
Net Cash Flow From Financing Activities$-250.01 Million
Net Cash Flow From Operating Activities, Continuing$262.95 Million
Net Cash Flow From Operating Activities$262.95 Million
Net Cash Flow From Investing Activities$-23.66 Million
Net Cash Flow$-8.53 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Income/Loss Available To Common Stockholders, Basic$205.95 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Benefits Costs and Expenses$849.33 Million
Diluted Average Shares$150.43 Million
Income Tax Expense/Benefit$61.02 Million
Revenues$1.11 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Income Tax Expense/Benefit, Deferred$17.71 Million
Costs And Expenses$851.69 Million
Operating Income/Loss$325.37 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Net Income/Loss$205.95 Million
Income/Loss From Continuing Operations Before Tax$261.33 Million
Gross Profit$613.16 Million
Net Income/Loss Attributable To Parent$205.95 Million
Cost Of Revenue$497.50 Million
Diluted Earnings Per Share$4.11
Income/Loss From Continuing Operations After Tax$205.95 Million
Basic Earnings Per Share$4.15
Operating Expenses$287.79 Million
Basic Average Shares$149.30 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Other Non-current Assets$544.72 Million
Intangible Assets$2.32 Billion
Current Assets$380.71 Million
Assets$3.32 Billion
Current Liabilities$106.91 Million
Equity$1.73 Billion
Liabilities$1.59 Billion
Wages$8.81 Million
Inventory$156.22 Million
Accounts Payable$31.17 Million
Equity Attributable To Parent$1.73 Billion
Fixed Assets$74.92 Million
Other Non-current Liabilities$426.63 Million
Equity Attributable To Noncontrolling Interest$0.00
Liabilities And Equity$3.32 Billion
Other Current Liabilities$51.21 Million
Noncurrent Liabilities$1.48 Billion
Other Current Assets$224.48 Million
Interest Payable$15.71 Million
Long-term Debt$1.05 Billion
Noncurrent Assets$2.94 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

ⓒ 2024 Financhle. All Rights Reserved.